Trends in Hospitalisations Due to Respiratory Syncytial Virus in Swedish Children: A Nationwide Study 2010–2022
Open Access
- 24 February 2026
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 115 (6) , 1258-1265
Abstract
Aim: Respiratory syncytial virus (RSV) infection is a leading cause of paediatric hospitalisations. This study describes annual RSV‐hospitalisation burden of disease, by gestational week of delivery, age and sex among children aged 0–17 years of age in Sweden, for the period 2010/11–2021/22. Methods: Employing total population Swedish register data pertaining to hospitalisations due to RSV for the period 2010–2022. Results: Over the study period a total of 26 772 children were hospitalised due to RSV. Most of the patients, 63.2%, were aged < 6 months and 39.9% were aged < 3 months. Among patients aged < 3 months, 88.5% were born at full term. The average number of hospital days increased with lower gestational age at birth for all age groups, except for patients aged 5‐ ≤ 17 years of age. Estimated incident rate ratios (IRR) comparing patients born at full term to patients born extremely preterm ranged between 2.43 and 1.75, respectively, for patients aged 0 < 3 months and 1 < 2 years of age. Conclusions: Paediatric RSV hospitalisations mostly occur in the youngest infants, and most are born at term. Gestational age at birth and age at admission are both negatively related to length of stay.Keywords
This publication has 21 references indexed in Scilit:
- Risk factors for severe outcomes of respiratory syncytial virus infection in children: a nationwide cohort study in SwedenThe Lancet Regional Health - Europe, 2025
- Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in DevelopmentReviews in Medical Virology, 2024
- Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized ChildrenThe Pediatric Infectious Disease Journal, 2024
- Pediatric RSV-Associated Hospitalizations Before and During the COVID-19 PandemicJAMA Network Open, 2023
- Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsNew England Journal of Medicine, 2023
- How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission InquiryActa Paediatrica, 2022
- A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 YearThe Journal of Infectious Diseases, 2022
- Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009–2019: A Study of the National (Nationwide) Inpatient SampleThe Journal of Infectious Diseases, 2022
- Incidence of Hospitalization for Respiratory Syncytial Virus Infection amongst Children in Ontario, Canada: A Population-Based Study Using Validated Health Administrative DataPLOS ONE, 2016
- Risk Factors for Hospital Admission with RSV Bronchiolitis in England: A Population-Based Birth Cohort StudyPLOS ONE, 2014